IL2 and head and neck squamous cell carcinoma: Nevertheless, we incubated isolated CD123+ BDCA-2+ HLA-DR+ cells with HNSCC and the T cell Expansion Kit (Miltenyi) in addition to IL-2 (20–200 U/l) for 3–7 days.